MNMD - Mind Medicine (MindMed) Inc. (MNMD) Q1 2024 Earnings Call Transcript
2024-05-08 21:07:02 ET
Mind Medicine (MindMed) Inc. (MNMD)
Q1 2024 Earnings Conference Call
May 08, 2024 04:30 PM ET
Company Participants
Robert Barrow - Chief Executive Officer
Daniel Karlin - Chief Medical Officer
Francois Lilienthal - Chief Commercial Officer
Conference Call Participants
Rudy Li - Leerink Partners LLC
Brian Abrahams - RBC Capital Markets
Elaine Kim - Cantor Fitzgerald
Daniel Hultberg - Oppenheimer
Sumant Kulkarni - Canaccord Genuity, LLC
Elemer Piros - Rodman & Renshaw
Patrick Trucchio - H.C. Wainwright & Co.
Presentation
Operator
Good day, and thank you for standing by. Welcome to the MindMed Q1 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your first speaker today, Rob Barrow, CEO of MindMed. Please go ahead.
Robert Barrow
Thank you, and good afternoon, everyone. Welcome to our first quarter 2024 financial results and corporate update conference call. The press release reporting our financial results is available in the Investors and Media section of our website, and our quarterly report on Form 10-Q for the quarter ended March 31, 2024, is being filed today with the Securities and Exchange Commission.
During today's call, we will be making certain forward-looking statements, including, without limitation, statements about the potential safety, efficacy, and regulatory and clinical progress of our product candidates, our anticipated cash runway, and our future expectations, plans, partnerships, and prospects. These statements are subject to various risks, such as changes in market conditions and difficulties associated with research and development and regulatory approval processes. These and other risk factors are described in the filings made with the SEC, including our annual report on Form 10-K and our Form 10-Q being filed today.
Forward-looking statements are based on the assumptions, opinions, and estimates of management at the date the statements are made, including the non-occurrence of the risks and uncertainties that are described in the filings made with the SEC or other significant events occurring outside of MindMed's normal course of business. You are cautioned not to place undue reliance on these forward-looking statements, which are made as of today, May 8, 2024. MindMed disclaims any obligation to update such statements, even if management's views change, except as required by law....
Mind Medicine (MindMed) Inc. (MNMD) Q1 2024 Earnings Call Transcript